MJ Pharma

Vorselaar ·KBO/BCE: BE 0755.612.578

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	31-07-2025	on the day	2025-00347275
31-12-2023	31-07-2024	30-07-2024	1 d early	2024-00317446
31-12-2022	31-07-2023	30-06-2023	31 d early	2023-00179580
31-12-2021	31-07-2022	23-08-2022	23 d late	2022-20305320

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€585k
Fixed assets	21/28	€479k
Financial fixed assets	28	€479k
Current assets	29/58	€106k
Amounts receivable within one year	40/41	€94k
Cash & bank	54/58	€12k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€585k
Equity	10/15	€216k
Contributions / capital	10/11	€3k
Reserves	13	€214k
Amounts payable	17/49	€369k
Amounts payable after one year	17	€287k
Amounts payable within one year	42/48	€83k
Trade debts payable within one year	44	€25k
Income statement
Gross operating margin	9900	€69k
Operating result	9901	€68k
Financial income	75	€58k
Financial charges	65	€5k
Result before taxes	9903	€121k
Income taxes	67/77	€25k
Net result for the period	9904	€96k
Result to be appropriated	9905	€96k

Summary